Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect

Zheng Zhou; Rahme, Elham; Abrahamowicz, Michal; Tu, Jack V.; Eisenberg, Mark J.; Humphries, Karin; Austin, Peter C.; Pilote, Louise
April 2005
CMAJ: Canadian Medical Association Journal;4/26/2005, Vol. 172 Issue 9, p1187
Academic Journal
Background: Clinical trials have shown the benefits of statins after acute myocardial infarction (AMI). However, it is unclear whether different statins exert a similar effect in reducing the incidence of recurrent AMI and death when used in clinical practice. Methods: We conducted a retrospective cohort study (1997-2002) to compare 5 statins using data from medical administrative databases in 3 provinces (Quebec, Ontario and British Columbia). We included patients aged 65 years and over who were discharged alive after their first AMI-related hospital stay and who began statin treatment within 90 days after discharge. The primary end point was the combined outcome of recurrent AMI or death from any cause. The secondary end point was death from any cause. Adjusted hazard ratios (HRs) for each statin compared with atorvastatin as the reference drug were estimated using Cox proportional hazards regression analysis. Results: A total of 18 637 patients were prescribed atorvastatin (n = 6420), pravastatin (n = 4480), simvastatin (n = 5518), lovastatin (n = 1736) or fluvastatin (n = 483). Users of different statins showed similar baseline characteristics and patterns of statin use. The adjusted HRs (and 95% confidence intervals) for the combined outcome of AMI or death showed that each statin had similar effects when compared with atorvastatin: pravastatin 1.00 (0.90-1.11), simvastatin 1.01 (0.91-1.12), lovastatin 1.09 (0.95-1.24) and fluvastatin 1.01 (0.80-1.27). The results did not change when death alone was the end point, nor did they change after adjustment for initial daily dose or after censoring of patients who switched or stopped the initial statin treatment. Interpretation: Our results suggest that, under current usage, statins are equally effective for secocondary prevention in elderly patients after AMI.


Related Articles

  • Are the benefits of statins a class effect? Wright, James M. // CMAJ: Canadian Medical Association Journal;4/26/2005, Vol. 172 Issue 9, p1195 

    Comments on the cohort study of the effectiveness of statins in elderly patients with acute myocardial infarction in Canada. Reasons the findings of the study are likely telling the truth; Claim on the similarity of statin doses based on cholesterol-lowering equivalents; Average cost of statin...

  • WHY SOME STATINS WORK BETTER.  // Time;9/13/2004, Vol. 164 Issue 11, p105 

    Mentions the findings that high doses of the cholesterol-lowering statin drug Lipitor lowered patients' levels of bad cholesterol and reduced their risk for heart attack. Results for patients who took the drug Zocor, a statin which does not reduce inflammation as well as Lipitor; Consideration...

  • Beneficial Effects of Statin Therapy on Survival in Hypertensive Patients With Acute Myocardial Infarction: Data From the RICO Survey Sicard, Pierre; Zeller, Marianne; Dentan, Gilles; Laurent, Yves; Touzery, Claude; L’huillier, Isabelle; Janin-Manificat, Luc; Lorgis, Luc; Beer, Jean-Claude; Makki, Hamib; Rochette, Luc; Cottin, Yves // American Journal of Hypertension;Nov2007, Vol. 20 Issue 11, p1133 

    Background: Randomized studies have shown a reduction in cardiovascular events associated with low doses of statin among hypertensive patients at only moderate cardiovascular risk. The hypothesis of the present study was that statin therapy initiated during hospitalization could improve the...

  • Increased statin prescribing could reduce MI mortality.  // PharmacoEconomics & Outcomes News;7/1/2006, Issue 506, p8 

    The article discusses research being done on the use of statin in myocardial infarction (MI). It references a study by P. C. Austin in the May 2006 issue of the "American Heart Journal." Several MI survivors discharged from hospitals in Ontario between April 1999 and March 2001 were included in...

  • Neighborhood socioeconomic characteristics and statin medication in patients with myocardial infarction: a Swedish nationwide follow-up study. Forsberg, Per-Ola; Xinjun Li; Sundquist, Kristina; Li, Xinjun // BMC Cardiovascular Disorders;7/8/2016, Vol. 16, p1 

    Background: Coronary heart disease (CHD) and myocardial infarction (MI) are associated with neighborhood-level socioeconomic status (SES). Statins are important drugs for secondary prevention of MI. However, no study has determined whether neighborhood-level SES is associated with...

  • STATINS COULD BE THE NEXT ASPIRIN. Simons, John // Fortune International (Europe);8/9/2004, Vol. 150 Issue 3, p15 

    Discusses how researchers from the University of Michigan found that statins may help to prevent various types of cancer. Findings that diabetics who take cholesterol-lowering drugs reduced their risk of stroke, heart attacks, and cardiovascular events; Possibility that statins may be used to...

  • STATINS COULD BE THE NEXT ASPIRIN. Simons, John // Fortune;8/9/2004, Vol. 150 Issue 3, p38 

    Discusses how researchers from the University of Michigan found that statins may help to prevent various types of cancer. Findings that diabetics who take cholesterol-lowering drugs reduced their risk of stroke, heart attacks, and cardiovascular events; Possibility that statins may be used to...

  • Can a statin reduce mortality and CV events in elderly CHD patients?  // Journal of Family Practice;Apr2008, Vol. 57 Issue 4, p223 

    The article elaborates on the significance of statin in reducing the mortality and cardiovascular (CV) events of older coronary heart disease (CHD) patients in the U.S. Researchers conducted their experiment on 28 elderly patients with CHD for five years and result shows such treatment will...

  • The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. Josan, Kiranbir; Majumdar, Sumit R.; McAlister, Finlay A. // CMAJ: Canadian Medical Association Journal;2/26/2008, Vol. 178 Issue 5, p576 

    The article investigates the efficacy and safety of different intensities of statin therapy in adults with coronary artery disease, using data from electronic databases, like MEDLINE, EMBASE and Web of Science. Findings reveal that intensive statin regimens lessen the patients' low-density...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics